Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intra‑arterial, intrathecal, and intravenous use. It provides radiopaque contrast that enhances visualization of vascular and tissue structures during diagnostic imaging procedures such as angiography, computed tomography (CT) and myelography.\n\nGNH India supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iopamiro is an iodinated contrast agent used to improve image quality in vascular and tissue imaging studies.\n\n- Angiography: enhances visualization of blood vessels and vascular lesions.\n- Computed tomography (CT) imaging: improves contrast between organs, vessels and lesions for accurate diagnosis.\n- Myelography: provides clear delineation of the spinal canal and nerve roots during contrast‑enhanced spinal imaging.

Iopamiro may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Warmth or flushing sensation at the injection site\n- Nausea or vomiting\n- Metallic taste or mild headache\n- Transient hypotension or mild dizziness\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (anaphylaxis)\n- Acute renal toxicity or worsening of pre‑existing kidney disease\n- Cardiac arrhythmias or severe hypotension\n- Pulmonary edema or seizures

Prior to using Iopamiro, several safety considerations should be observed.\n\n- Renal function assessment: evaluate serum creatinine and eGFR before administration.\n- Iodine allergy check: confirm no known hypersensitivity to iodinated contrast.\n- Thyroid disease caution: avoid in patients with uncontrolled hyperthyroidism.\n- Use lowest effective dose: tailor volume to imaging requirement.\n- Monitor vital signs: observe blood pressure and heart rate during and after injection.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iopamiro can interact with other medications, requiring attention to avoid adverse outcomes.\n\nMajor Interactions (Avoid):\n- Concurrent use of other iodinated contrast agents: risk of cumulative iodine load.\n- Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal injury.\n- Thyroid hormone therapy: excess iodine can alter thyroid hormone levels.\n\nModerate Interactions (Monitor Closely):\n- Diuretics and ACE inhibitors: monitor renal function and electrolytes.\n- Metformin: temporary discontinuation may be needed to prevent lactic acidosis in renal impairment.\n- Anticoagulants: watch for bleeding complications due to vascular irritation.